Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nanosonics.
RELATED STOCKHEAD STORIES
News
With America vaccinating 2 million a day, here are 3 ASX medtechs that will benefit as lockdowns are lifted
Experts
MoneyTalks: Could this ASX medtech stock become the next Cochlear?
Experts
Scopo’s health powerplays: Nanosonics plays out ‘really well’ for Morgans
News
Afterpay just joined the top 20 ASX stocks; how many others were once small caps?
Experts
ScoPo’s powerplays: Healthcare hit by ‘Covid exit trade’, but opportunities remain
Experts
Scopo’s powerplays: Feeling bullish for end of 2020
Tech
Since 2017, ASX tech disruptors have put ‘value’ stocks on the mat
Experts
Scopo’s health powerplays: A healthy earnings season
Experts
Scopo’s powerplays: Investors love a result, until they don’t
Health & Biotech
How tech is changing healthcare, and where professional ASX investors are looking
Health & Biotech
COVID-19 adds $9bn to top four ASX health stocks
Experts
Scopo’s health powerplays: Health goes up when markets go down
Health & Biotech
Dr Boreham’s Crucible: Will EMVision’s links to Nanosonics set it up for similar success?
Health & Biotech
We’re still here: investors keen on health despite market shun
Experts
ScoPo’s health powerplays: How to invest in COVID-19
Stockhead TV
VIDEO: The boom continues – 2019 tech sector wrap
Health & Biotech